Year: 2025

EUR 540,000 administrative fine imposed on Verkkokauppa.com by Regional State Administrative Agency for deficiencies in anti-money laundering legislation compliance

Written by Customer Service on October 30, 2025. Posted in Public Companies.

EUR 540,000 administrative fine imposed on Verkkokauppa.com by Regional State Administrative Agency for deficiencies in anti-money laundering legislation compliance Verkkokauppa.com Oyj Press Release 30 October 2025 at 12.25 EET Verkkokauppa.com has today received a notification of the Regional State Administrative Agency for Southern Finland’s decision to impose an administrative fine of EUR 540,000 on Verkkokauppa.com. The decision is based on an inspection conducted by the Regional State Administrative Agency in 2023 concerning the Company’s practices related to compliance with the Anti-Money Laundering Act during the period from 1 September 2020 to 31 August 2023. In its decision, the Regional State Administrative Agency concluded that the documentation and processes required under the Anti-Money Laundering...

Integra LifeSciences Reports Third Quarter 2025 Financial Results

Written by Customer Service on October 30, 2025. Posted in Earnings Releases And Operating Results.

PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025. Third Quarter 2025 HighlightsThird quarter revenues of $402.1 million increased 5.6% on a reported basis and 5.0% on an organic basis compared to the prior year.Third quarter GAAP earnings per diluted share of $(0.07), compared to $(0.14) in the prior year.Adjusted earnings per diluted share of $0.54, compared to $0.41 in the prior year.Relaunch of PriMatrix® and Durepair® ahead of schedule, through dual sourcing supply strategy.Appointed Dr. Raymond Turner, a board-certified neurosurgeon, fellowship-trained in endovascular neurosurgery, as chief medical officer.Revising 2025 guidance...

Perimeter Solutions Reports Third Quarter 2025 Financial Results

Written by Customer Service on October 30, 2025. Posted in Earnings Releases And Operating Results.

Third quarter Net Loss of $90.7M and Adjusted Net Income of $125.5M Continued value driver execution drove third quarter Adjusted EBITDA of $186.3M Third quarter Loss Per Diluted Share of $0.62 and Adjusted Earnings Per Diluted Share of $0.82 IMS add-on product lines acquired CLAYTON, Mo., Oct. 30, 2025 (GLOBE NEWSWIRE) — Perimeter Solutions, Inc. (NYSE: PRM) (“Perimeter,” “Perimeter Solutions,” or the “Company”), a leading global solutions provider for the Fire Safety and Specialty Products industries, today reported financial results for its third quarter ended September 30, 2025. Third Quarter 2025 ResultsNet sales increased 9% to $315.4 million in the third quarter, as compared to $288.4 million in the prior-year quarter.Fire Safety net sales increased 9% to $273.4 million, as compared to $251.8 million in the prior year...

LXP Industrial Trust Reports Third Quarter 2025 Results

Written by Customer Service on October 30, 2025. Posted in Earnings Releases And Operating Results.

Board Authorizes 3.7% Dividend Increase WEST PALM BEACH, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — LXP Industrial Trust (“LXP”) (NYSE: LXP), a real estate investment trust focused on Class A warehouse and distribution real estate investments, today announced results for the quarter ended September 30, 2025. Third Quarter 2025 HighlightsRecorded Net Income attributable to common shareholders of $34.6 million, or $0.12 per diluted common share. Generated Adjusted Company Funds From Operations available to all equityholders – diluted (“Adjusted Company FFO”) of $46.7 million, or $0.16 per diluted common share. Sold two vacant development projects totaling 2.1 million square feet to a user buyer for $175 million, representing a 20% premium over the gross book value. Increased the Stabilized Portfolio leased percentage to 96.8%....

Amneal Reports Third Quarter 2025 Financial Results

Written by Customer Service on October 30, 2025. Posted in Earnings Releases And Operating Results.

‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced its results for the third quarter ended September 30, 2025. “Amneal delivered another strong quarter and updated our 2025 outlook, underscoring the strength of our diversified business and the ongoing evolution of our portfolio. CREXONT® for Parkinson’s disease and other key branded products continue to drive Specialty growth, complemented by the launch this month of BREKIYA® in the migraine space. At the same time, our Affordable Medicines segment is entering a significant new product launch...

FirstCash Reports Record Third Quarter Operating Results Across All Segments; Recent U.K. Acquisition Drives Additional Revenue and Earnings Growth; Declares Quarterly Cash Dividend and Authorizes New $150 Million Share Repurchase Plan

Written by Customer Service on October 30, 2025. Posted in Earnings Releases And Operating Results.

FORT WORTH, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) — FirstCash Holdings, Inc. (“FirstCash” or the “Company”) (Nasdaq: FCFS), the leading international operator of more than 3,300 retail pawn stores, today announced record revenue and earning results for the three and nine month periods ended September 30, 2025. The Company also announced that the Board of Directors declared a quarterly cash dividend of $0.42 per share, which will be paid in November 2025, and authorized a new $150 million share repurchase plan. Mr. Rick Wessel, chief executive officer, stated, “FirstCash’s third quarter operating results were outstanding, evidenced by accelerating revenue growth, strong margins and continued earnings growth in both the U.S. and Latin American pawn segments coupled with a strong partial quarter contribution from the recently acquired...

KBR Reports Third Quarter Fiscal 2025 Results

Written by Customer Service on October 30, 2025. Posted in Earnings Releases And Operating Results.

Third Quarter Fiscal 2025 Highlights(All comparisons against the third quarter fiscal 2024 unless noted.)Revenues of $1.9 billion Net income attributable to KBR (including discontinued operations) of $115 million; Adjusted EBITDA2 of $240 million, up 10% with an Adjusted EBITDA2 margin of 12.4% Diluted EPS (including discontinued operations) of $0.90; Adjusted EPS2 of $1.02, up 21% Bookings and options1 of $4.2 billion with 1.4x book-to-bill1Third Quarter YTD 2025 Highlights(All comparisons against the third quarter YTD fiscal 2024 unless noted.)Revenues of $5.9 billion, up 5% Net income attributable to KBR (including discontinued operations) of $304 million; Adjusted EBITDA2 of $730 million, up 14% with an Adjusted EBITDA2 margin of 12.4% Diluted EPS (including discontinued operations) of $2.33; Adjusted EPS2 of $2.93, up 20% Bookings...

Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting

Written by Customer Service on October 30, 2025. Posted in Public Companies.

Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher Scientific LOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces its Corporate and Scientific presentations, and exhibitor presence at the 2025 AMP Annual Meeting, November 12-15, in Boston, MA. BIODESIX WORKSHOP: On November 12, at 4:00 ET, Dr. Gary Pestano, Chief Development Officer, will lead a Biodesix Corporate Workshop focused on the company’s R&D Roadmap, including both near- and longer-term novel diagnostic services and solutions. The panel will include updates from key partners of Biodesix Development Services: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories,...

Comstock Announces Third Quarter 2025 Results And Corporate Updates

Written by Customer Service on October 30, 2025. Posted in Earnings Releases And Operating Results.

Fortifies Capital Base, Eliminates Debt Obligations and Funds Industry-scale Metals Launch VIRGINIA CITY, Nev., Oct. 30, 2025 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock,” “our,” and the “Company”), today announced its third quarter 2025 financial results, business updates and an updated 2025 business outlook. Recent Corporate Transactional and Liquidity and Capital Resources HighlightsCompleted the oversubscribed equity raise of $34.5 million in gross proceeds ($31.8 million net of offering expenses), including overallotment, adding over 30 institutional investors to our capital base and fully funding and accelerating the commercialization of our R2v3/RIOS Responsible Recycling certified zero-landfill solar panel recycling business; Eliminated all debt instruments (convertible and promissory notes) and other significant...

WTW Reports Third Quarter 2025 Earnings

Written by Customer Service on October 30, 2025. Posted in Earnings Releases And Operating Results.

Revenue1 of $2.3 billion was flat compared to prior-year quarter due to the sale of TRANZACT Organic Revenue growth of 5% for the quarter Diluted Earnings per Share2 was $3.11 for the quarter Adjusted Diluted Earnings per Share was $3.07 for the quarter, up 11% over prior year3 Operating Margin2 was 18.3% for the quarter Adjusted Operating Margin was 20.4% for the quarter, up 230 basis points from prior yearLONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW) (the “Company”), a leading global advisory, broking and solutions company, today announced financial results for the third quarter ended September 30, 2025. “WTW’s market-leading solutions and focused execution on our strategy drove another quarter of strong results,” said Carl Hess, WTW’s Chief Executive Officer. “In the third quarter, we delivered a solid revenue...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals